Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

APYX - Apyx Medical Corporation Последние новости | Finranks

Home

/

APYX

A

Apyx Medical Corporation (APYX)

NMS – Цена в реальном времени. Валюта: USD

2.99

-0.03 (-0.99%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

2.99

0.00 (0.00%)

После закрытия: Aug 12, 2026, 4:10 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring

Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring

Apyx Medical NASDAQ: APYX is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwin said has been reshaped by the increasing use of GLP-1 weight-loss drugs.

Apyx Medical Corporation (APYX) Q2 2026 Earnings Call Transcript

Apyx Medical Corporation (APYX) Q2 2026 Earnings Call Transcript

Apyx Medical Corporation (APYX) Q2 2026 Earnings Call Transcript

Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates

Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates

Apyx Medical (APYX) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.09 per share a year ago.

Apyx Medical Q2 Earnings Call Highlights

Apyx Medical Q2 Earnings Call Highlights

Apyx Medical NASDAQ: APYX reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international generator sales and domestic demand for single-use handpieces.

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

CLEARWATER, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its second quarter ended June 30, 2026.

Видео

No Data

There is no data to display

Пресс-релизы

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

CLEARWATER, Fla., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its second quarter ended June 30, 2026.